NYSE ARCA | ETF
The fund invests primarily in common stocks of issuers outside of the United States that the investment adviser believes have the potential for growth, many of which have the potential to pay dividends.
Under normal market conditions, the fund will invest at least 80% of its net assets in equity securities, and at least 80% of its net assets in securities outside the United States.
The fund is non-diversified.
Top 12 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 4.39% |
SAF | Safran SA | Industrials | Aerospace & Defense | 3.41% |
TTE | TotalEnergies SE | Energy | Oil & Gas Integrated | 3.03% |
SAP | SAP SE | Technology | Software - Application | 2.94% |
ASML | ASML Holding NV | Technology | Semiconductor Equipment & Materials | 2.93% |
AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.70% |
LSEG | London Stock Exchange Group PLC | Financial Services | Financial Data & Stock Exchanges | 2.25% |
NESN | Nestlé S.A. | Consumer Defensive | Packaged Foods | 2.18% |
SIKA | Sika AG | Basic Materials | Specialty Chemicals | 2.18% |
OR | L’Oreal SA | Consumer Defensive | Household & Personal Products | 2.01% |
TSM | Taiwan Semiconductor Manufacturing | Technology | Semiconductors | 2.00% |
EL | EssilorLuxottica S. A. | Healthcare | Medical Instruments & Supplies | 1.99% |